UK Biotech Co. Abcam Expands With $170M Epitomics Buy

By Amanda Bransford · March 5, 2012, 1:15 PM EST

U.K. life sciences company Abcam PLC has agreed to spend $170 million to acquire U.S. company Epitomics International Inc., which provides antibodies to researchers, as part of a strategy to expand...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Amanda

July 16, 2012
Mayer Brown Tells 7th Circ. $17M Malpractice Suit Is Absurd
June 04, 2012
High Court Refuses Ex-Ala. Governor's Appeal In Bribery Case
May 30, 2012
DC Circ. Tells Armey To Take Up Medicare Beef With Insurer
May 14, 2012
High Court Won't Hear CUNA Retirees' Health Benefit Appeal
May 11, 2012
Insurers Deny They Owe Costs For Mining Co.'s Asbestos Feuds
April 16, 2012
UnitedHealth, Lexington End Coverage Feud In 1st Circ.
April 13, 2012
Continental Wants Limits On Asbestos Coverage For Mead
March 21, 2012
Insurers Stuck In Asbestos Duty-To-Defend Suit
March 16, 2012
Federal Plan To Share Health Insurance Risk Is Released
March 07, 2012
Amgen Seeks High Court Review Of Investor Class Cert.